Cerebra Integrated Technologies Fair Value
Cerebra Integrated Technologies (CEREBRAINT) average fair value is ₹31.14 across 3 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, vs a current market price of ₹3.3 (+843.54%), fair value range ₹0.49–₹78.37. See CEREBRAINT price book multiple to compare market price against book value per share.
Fair Value Analysis Export
CEREBRAINT Fair Value vs Current Price — Valuation Summary
CEREBRAINT average fair value, fair value range, price gap and valuation status across 3 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation. Examine Cerebra Integrated Technologie quarterly earnings for recent quarterly revenue, profit and EPS trends.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
CEREBRAINT Fair Value Analysis — Data Sources & Coverage
Cerebra Integrated Technologies financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. For live price and a broader fundamental view, visit Cerebra Integrated Technologie share price chart.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
CEREBRAINT vs Information Technology Sector Peers — P/E, P/B & Market Cap
Cerebra Integrated Technologies P/E ratio, P/B ratio and market capitalisation vs Information Technology sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Aion Tech Solutions | GOLDTECH | 48.47 | 0.72 | ₹218 |
| Covance Softsol | COVANCE | 14.5 | 2.58 | ₹379 |
| Fractal Analytics | FRACTAL | 56.29 | 5.07 | ₹16,079 |
| SILVERLINE | SILVERLINE | 4.74 | 0.77 | ₹103 |
| Inspirisys Solutions | INSPIRISYS | 10.1 | 4.13 | ₹430 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.